Browse AMR Genes
Explore antimicrobial resistance genes from the literature
Explore antimicrobial resistance genes from the literature
global regulator
Overview
| Protein Change | Nucleotide Change | Mechanism | Organism | Resistance To | Database | Validation Status |
|---|---|---|---|---|---|---|
| R77L | - | single resistance variant, transcriptional regulator MarR | Escherichia coli | Multiple antibioticsAMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE | Card DatabaseReference Gene Catalog | Confirmed |
| V96E | - | single resistance variant, transcriptional regulator MarR | Escherichia coli | Multiple antibioticsAMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE | Card DatabaseReference Gene Catalog |
| Confirmed |
| R77C | - | single resistance variant, transcriptional regulator MarR | Escherichia coli | Multiple antibioticsAMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE | Card DatabaseReference Gene Catalog | Confirmed |
| Y137H | - | single resistance variant | Escherichia coli, Escherichia spp. | Multiple antibioticsTigecyclineCiprofloxacin | Card DatabaseReslit | Confirmed |
| R94H | single resistance variant, transcriptional regulator MarR | Escherichia coli, E. coli | Multiple antibioticsCiprofloxacinAMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE+1 more | Card DatabaseReference Gene CatalogReslit | Confirmed |
| R58L | - | single resistance variant | Escherichia coli | Multiple antibiotics | Card Database | Established |
| G103S | - | single resistance variant | Escherichia coli, Escherichia spp. | Multiple antibioticsNalidixic acid|Ciprofloxacin|Ampicillin|Kanamycin|Streptomycin|Rifampin|Tetracycline|Chloramphenicol|Trimethoprim|SulfamethoxazoleTigecycline+2 more | Card DatabaseReslit | Confirmed |
| S3N | - | single resistance variant, transcriptional regulator MarR | Escherichia coli | Multiple antibioticsFluoroquinolonesChloramphenicol|Rifampin+1 more | Card DatabaseReference Gene CatalogReslit | Confirmed |
| V45E | - | single resistance variant, transcriptional regulator MarR | Escherichia coli | Multiple antibioticsAMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE | Card DatabaseReference Gene Catalog | Confirmed |
| R73C | - | single resistance variant, transcriptional regulator MarR | Escherichia coli | Multiple antibioticsAMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE | Card DatabaseReference Gene Catalog | Confirmed |
| L78M | - | single resistance variant, transcriptional regulator MarR | Escherichia coli | Multiple antibioticsAMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE | Card DatabaseReference Gene Catalog | Confirmed |
| R73S | - | single resistance variant, transcriptional regulator MarR | Escherichia coli | Multiple antibioticsChloramphenicolAMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINE | Card DatabaseReference Gene CatalogReslit | Confirmed |
| T39I | - | - | Escherichia coli | Ciprofloxacin | Reslit | Candidate |
| M74I | - | - | E. coli | Tetracycline | Reslit | Candidate |
| C108Y | - | loss-of-function | Escherichia coli | Ampicillin|Tetracycline | Reslit | Candidate |
| L46P | - | loss-of-function | Escherichia coli | Ampicillin|Tetracycline | Reslit | Candidate |
| R296H | - | - | Escherichia coli | Chloramphenicol | Reslit | Candidate |
| G22D | - | - | Escherichia coli | Ampicillin | Reslit | Candidate |
| G28R | - | - | Escherichia coli | Fluoroquinolones | Reslit | Candidate |
| M1V | - | - | - | CarbapenemCarbapenem|Colistin | Reslit | Candidate |
| V66A | - | - | Escherichia coli | Ceftriaxone | Reslit | Candidate |
| R62C | - | - | Escherichia coli | Gatifloxacin | Reslit | Candidate |
| S83L | - | Escherichia coli | Ciprofloxacin | Reslit | Candidate |
| A53E | - | - | - | Tigecycline | Reslit | Candidate |
| M1G | - | - | - | Tigecycline | Reslit | Candidate |
| L71P | - | - | - | Tigecycline | Reslit | Candidate |
| K44Y | - | - | - | Tigecycline | Reslit | Candidate |
| V84E | - | - | E. coli, Escherichia coli | Chloramphenicol|CiprofloxacinCiprofloxacin | Reslit | Candidate |
| L109F | - | - | E. coli | Chloramphenicol | Reslit | Candidate |
| V11I | - | mutations that relieve transcriptional repression by MarR consequently upregulate the expression of the efflux pump and increase antibiotic resistance | Shewanella oneidensis | Ciprofloxacin | Reslit | Candidate |
| L78R | - | - | Escherichia coli | Ciprofloxacin | Reslit | Candidate |
| E136D | - | - | Escherichia coli | Ciprofloxacin | Reslit | Candidate |
| 22fs | - | loss of repressor activity | Escherichia coli | Ciprofloxacin | Reslit | Candidate |
| Q42E | - | - | Escherichia coli | Levofloxacin | Reslit | Candidate |
| R27P | - | - | Escherichia coli | Levofloxacin | Reslit | Candidate |
| G81C | - | - | Escherichia coli | Ciprofloxacin | Reslit | Candidate |
| G69E | - | Escherichia coli | LevofloxacinChloramphenicolDelafloxacin|Ciprofloxacin | Reslit | Supported |
| G81D | - | - | Escherichia coli | Ciprofloxacin | Reslit | Candidate |
| T102S | - | - | Escherichia coli | Levofloxacin | Reslit | Candidate |
| D87G | - | - | Escherichia coli | Ciprofloxacin|Levofloxacin | Reslit | Candidate |
| L123S | - | - | Escherichia coli | Levofloxacin | Reslit | Candidate |
| L33R | - | - | Escherichia coli | Levofloxacin | Reslit | Candidate |
| L115P | - | - | - | Ciprofloxacin | Reslit | Candidate |
| D67Y | - | - | E. coli | Ciprofloxacin | Reslit | Candidate |
| G104C | - | - | E. coli | Ciprofloxacin | Reslit | Candidate |
| W63R | - | - | E. coli | Ciprofloxacin | Reslit | Candidate |
| R152C | - | - | Escherichia coli | Benzalkonium chloride|Chloramphenicol|Triclosan | Reslit | Candidate |
| V41M | - | - | Escherichia coli | Benzalkonium chloride|Chloramphenicol|Triclosan | Reslit | Candidate |
| L75R | - | - | Escherichia coli | Ciprofloxacin | Reslit | Candidate |
| D67N | - | - | Escherichia coli | Fluoroquinolones | Reslit | Candidate |
| V66F | - | - | Escherichia coli | Ampicillin | Reslit | Candidate |
| E31Ter | - | transcriptional regulator MarR, nonsense mutation | Escherichia coli | AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINEMultiple antibiotics | Card DatabaseReference Gene Catalog | Confirmed |
| A70T | - | transcriptional regulator MarR, single resistance variant | Escherichia coli | AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINEMultiple antibiotics | Card DatabaseReference Gene Catalog | Confirmed |
| I49S | - | transcriptional regulator MarR, single resistance variant | Escherichia coli | AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINEMultiple antibiotics | Card DatabaseReference Gene Catalog | Confirmed |
| R94S | - | transcriptional regulator MarR, single resistance variant | Escherichia coli | AMPICILLIN/CHLORAMPHENICOL/QUINOLONE/RIFAMPIN/TETRACYCLINEMultiple antibiotics | Card DatabaseReference Gene Catalog | Confirmed |
| - | - | Escherichia coli | Chloramphenicol | Reslit | Candidate |
| T72P | - | - | Delafloxacin | Reslit | Candidate |
| - | - | Escherichia coli | Norfloxacin | Reslit | Candidate |
| - | - | Salmonella enterica | Ciprofloxacin | Reslit | Candidate |
| G69R | - | - | Delafloxacin | Reslit | Candidate |
| R86S | - | - | Ciprofloxacin | Reslit | Candidate |
| G106D | - | Escherichia coli | Tetracycline|Chloramphenicol | Reslit | Candidate |
| M74T | - | E. coli | Tetracycline | Reslit | Candidate |
| L87W | - | - | Ciprofloxacin | Reslit | Candidate |
| Allele | Database | Papers | Drug Classes | Organisms | Countries | Years | Sequence Accession | Protein Accession |
|---|---|---|---|---|---|---|---|---|
| mar | Reslit | 2 | Tetracycline, Nalidixic acid +1 | Escherichia coli O157:H7 +1 | - | 2004, 2012 | - | - |
| mar R | Reslit | 1 | Multiple antibiotics | Escherichia coli +1 | North America | 2023 | ERP146025 | - |
Intrinsic mechanism decreases susceptibility of Escherichia coli O157:H7 to multiple antibiotics.
Chloramphenicol-resistant mutants of Escherichia coli O157:H7 showed increased resistance to tetracycline, nalidixic acid, and ciprofloxacin. Mutation in the mar operon was linked to decreased susceptibility.
Trade-offs between drug toxicity and benefit in the multi-antibiotic resistance system underlie optimal growth of E. coli.
Impact of immigration on antibiotic resistance genes in activated sludge: A study using digital droplet PCR and amplicon sequencing
The study reveals that immigration of influent wastewater into activated sludge leads to an increase in the abundance of over 70% of the quantified antibiotic resistance genes (ARGs). Specific ARGs such as blaTEM, blaMOX, qnrS, qnrB, mphE, dfrA, tetO, tetQ, tetE, marR, msrD, robA, qacL, blaOXA, and ereA were found to increase in abundance with immigration, indicating the impact of influent immigration on the persistence of AMR in wastewater treatment plants.
No comments yet. Be the first to comment!
© 2026 ResLit. Data sourced from PubMed literature analysis.
Built for antimicrobial resistance research